 Betsy Risendal
Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Survivors | 12 | 2015 | 366 | 2.040 |
Why?
| | Breast Neoplasms | 22 | 2015 | 1829 | 1.750 |
Why?
| | Neoplasms | 12 | 2021 | 1941 | 1.530 |
Why?
| | Patient Navigation | 3 | 2018 | 61 | 1.480 |
Why?
| | Colorectal Neoplasms | 6 | 2020 | 517 | 1.150 |
Why?
| | Hispanic Americans | 14 | 2013 | 1070 | 1.120 |
Why?
| | Cancer Survivors | 3 | 2021 | 117 | 1.080 |
Why?
| | European Continental Ancestry Group | 13 | 2013 | 1345 | 1.020 |
Why?
| | Health Plan Implementation | 3 | 2018 | 132 | 0.870 |
Why?
| | Patient Care Planning | 4 | 2015 | 160 | 0.710 |
Why?
| | Patient Advocacy | 1 | 2017 | 69 | 0.690 |
Why?
| | Early Detection of Cancer | 5 | 2021 | 265 | 0.610 |
Why?
| | Specialization | 1 | 2015 | 120 | 0.570 |
Why?
| | Delivery of Health Care | 4 | 2021 | 650 | 0.540 |
Why?
| | Quality of Life | 3 | 2020 | 1972 | 0.540 |
Why?
| | Translational Medical Research | 2 | 2017 | 211 | 0.530 |
Why?
| | Registries | 2 | 2020 | 1739 | 0.500 |
Why?
| | Physicians, Primary Care | 1 | 2015 | 243 | 0.470 |
Why?
| | Self Care | 1 | 2014 | 361 | 0.470 |
Why?
| | Cross-Sectional Studies | 10 | 2020 | 3985 | 0.450 |
Why?
| | Research Design | 2 | 2018 | 861 | 0.440 |
Why?
| | Indians, North American | 3 | 1999 | 584 | 0.410 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 566 | 0.410 |
Why?
| | Health Knowledge, Attitudes, Practice | 5 | 2014 | 1197 | 0.410 |
Why?
| | Patient-Centered Care | 1 | 2014 | 451 | 0.400 |
Why?
| | Chronic Disease | 2 | 2015 | 1650 | 0.400 |
Why?
| | Weight Gain | 1 | 2013 | 486 | 0.390 |
Why?
| | Middle Aged | 28 | 2021 | 28539 | 0.380 |
Why?
| | Family Health | 1 | 2008 | 214 | 0.360 |
Why?
| | Safety-net Providers | 2 | 2018 | 100 | 0.340 |
Why?
| | Logistic Models | 10 | 2019 | 2016 | 0.340 |
Why?
| | Continuity of Patient Care | 3 | 2015 | 273 | 0.340 |
Why?
| | Aged | 20 | 2021 | 19759 | 0.320 |
Why?
| | Practice Patterns, Physicians' | 1 | 2015 | 1182 | 0.320 |
Why?
| | Quality of Health Care | 1 | 2011 | 639 | 0.320 |
Why?
| | Mass Screening | 5 | 2014 | 990 | 0.320 |
Why?
| | Mammography | 3 | 2010 | 140 | 0.310 |
Why?
| | Humans | 44 | 2021 | 109171 | 0.310 |
Why?
| | Case-Control Studies | 7 | 2020 | 3324 | 0.310 |
Why?
| | Female | 34 | 2020 | 61606 | 0.310 |
Why?
| | Arizona | 4 | 2013 | 63 | 0.290 |
Why?
| | Uterine Cervical Neoplasms | 2 | 2014 | 223 | 0.290 |
Why?
| | Adult | 25 | 2019 | 31455 | 0.280 |
Why?
| | Odds Ratio | 5 | 2013 | 1046 | 0.280 |
Why?
| | Surveys and Questionnaires | 8 | 2018 | 4375 | 0.270 |
Why?
| | Exercise | 1 | 2014 | 1608 | 0.270 |
Why?
| | Healthcare Disparities | 3 | 2017 | 431 | 0.250 |
Why?
| | United States | 13 | 2021 | 11627 | 0.220 |
Why?
| | Vaginal Smears | 1 | 1999 | 45 | 0.210 |
Why?
| | Risk Factors | 12 | 2019 | 8786 | 0.210 |
Why?
| | Papanicolaou Test | 1 | 1999 | 43 | 0.210 |
Why?
| | Health Priorities | 1 | 1999 | 42 | 0.200 |
Why?
| | Unemployment | 1 | 2019 | 38 | 0.200 |
Why?
| | Research | 3 | 2018 | 441 | 0.190 |
Why?
| | Primary Health Care | 3 | 2018 | 1452 | 0.190 |
Why?
| | Patient Education as Topic | 2 | 2014 | 742 | 0.180 |
Why?
| | Congresses as Topic | 1 | 2019 | 205 | 0.180 |
Why?
| | Preventive Medicine | 1 | 2017 | 37 | 0.170 |
Why?
| | Age Factors | 7 | 2019 | 3307 | 0.170 |
Why?
| | Evidence-Based Practice | 1 | 2018 | 165 | 0.160 |
Why?
| | Follow-Up Studies | 3 | 2015 | 4830 | 0.160 |
Why?
| | Public Health | 1 | 2021 | 407 | 0.160 |
Why?
| | Health Planning | 1 | 2015 | 47 | 0.150 |
Why?
| | Comorbidity | 1 | 2020 | 1580 | 0.150 |
Why?
| | Transition to Adult Care | 1 | 2015 | 45 | 0.150 |
Why?
| | Community Health Centers | 1 | 2014 | 55 | 0.150 |
Why?
| | Health Status | 1 | 2020 | 765 | 0.140 |
Why?
| | Anniversaries and Special Events | 1 | 2014 | 14 | 0.140 |
Why?
| | Patient Acceptance of Health Care | 2 | 2018 | 619 | 0.140 |
Why?
| | Diagnostic Tests, Routine | 1 | 2015 | 94 | 0.140 |
Why?
| | Diffusion of Innovation | 1 | 2014 | 103 | 0.140 |
Why?
| | Medical Oncology | 1 | 2015 | 168 | 0.140 |
Why?
| | Ambulatory Care Facilities | 1 | 2015 | 194 | 0.130 |
Why?
| | Health Behavior | 1 | 1999 | 708 | 0.130 |
Why?
| | Program Evaluation | 2 | 2015 | 842 | 0.130 |
Why?
| | Disease Management | 2 | 2015 | 595 | 0.130 |
Why?
| | Genetic Testing | 1 | 2015 | 375 | 0.130 |
Why?
| | Receptors, Estrogen | 3 | 2013 | 374 | 0.130 |
Why?
| | New Mexico | 1 | 2013 | 67 | 0.130 |
Why?
| | Incidence | 4 | 2019 | 2353 | 0.130 |
Why?
| | Age of Onset | 2 | 2019 | 502 | 0.130 |
Why?
| | Health Personnel | 1 | 2018 | 459 | 0.130 |
Why?
| | Vitamin B Complex | 1 | 2013 | 39 | 0.130 |
Why?
| | Body Weight | 2 | 2013 | 1039 | 0.130 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2012 | 48 | 0.130 |
Why?
| | Methionine | 1 | 2013 | 142 | 0.120 |
Why?
| | Feasibility Studies | 1 | 2014 | 693 | 0.120 |
Why?
| | Health Services Accessibility | 2 | 2014 | 749 | 0.120 |
Why?
| | Folic Acid | 1 | 2013 | 151 | 0.120 |
Why?
| | Socioeconomic Factors | 4 | 2013 | 1178 | 0.120 |
Why?
| | Patient Participation | 1 | 2014 | 320 | 0.110 |
Why?
| | Male | 7 | 2020 | 60174 | 0.110 |
Why?
| | Guideline Adherence | 1 | 2015 | 522 | 0.110 |
Why?
| | Patient Satisfaction | 1 | 2015 | 584 | 0.110 |
Why?
| | Obesity | 3 | 2013 | 2587 | 0.110 |
Why?
| | Interviews as Topic | 2 | 2013 | 599 | 0.110 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2009 | 37 | 0.110 |
Why?
| | Survival Rate | 2 | 2011 | 1821 | 0.100 |
Why?
| | Southwestern United States | 4 | 2011 | 100 | 0.100 |
Why?
| | Hydroxyestrones | 1 | 2009 | 3 | 0.100 |
Why?
| | Patient Care Team | 1 | 2014 | 517 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2021 | 2151 | 0.090 |
Why?
| | Colorado | 3 | 2015 | 4514 | 0.090 |
Why?
| | Confidence Intervals | 1 | 2008 | 345 | 0.090 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2009 | 271 | 0.090 |
Why?
| | Urinary Incontinence | 1 | 2008 | 57 | 0.090 |
Why?
| | Health Promotion | 1 | 2014 | 648 | 0.090 |
Why?
| | Prognosis | 2 | 2013 | 3445 | 0.080 |
Why?
| | Practice Guidelines as Topic | 1 | 2014 | 1541 | 0.080 |
Why?
| | Multivariate Analysis | 2 | 1999 | 1597 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 3 | 2010 | 2368 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2018 | 2840 | 0.070 |
Why?
| | Patient Compliance | 1 | 2009 | 618 | 0.070 |
Why?
| | Psychometrics | 2 | 2018 | 640 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2009 | 987 | 0.070 |
Why?
| | Phenotype | 1 | 2011 | 2968 | 0.060 |
Why?
| | Cohort Studies | 1 | 2013 | 4804 | 0.060 |
Why?
| | Ethnic Groups | 2 | 2010 | 657 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2012 | 1866 | 0.060 |
Why?
| | Prospective Studies | 1 | 2013 | 5942 | 0.060 |
Why?
| | Survivorship | 1 | 2021 | 16 | 0.060 |
Why?
| | Young Adult | 4 | 2019 | 10686 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2007 | 879 | 0.050 |
Why?
| | Alcohol Drinking | 2 | 2011 | 697 | 0.050 |
Why?
| | Financing, Personal | 1 | 2019 | 28 | 0.050 |
Why?
| | Minority Groups | 1 | 2000 | 188 | 0.050 |
Why?
| | Body Mass Index | 3 | 2013 | 2073 | 0.050 |
Why?
| | Culture | 1 | 1999 | 137 | 0.050 |
Why?
| | Menopause | 2 | 2011 | 249 | 0.050 |
Why?
| | Risk | 2 | 2012 | 950 | 0.040 |
Why?
| | Medicaid | 1 | 2021 | 342 | 0.040 |
Why?
| | Postmenopause | 2 | 2009 | 330 | 0.040 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 290 | 0.040 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 197 | 0.040 |
Why?
| | Medicare | 1 | 2021 | 551 | 0.040 |
Why?
| | Health Status Disparities | 1 | 2019 | 205 | 0.040 |
Why?
| | Urban Population | 1 | 1999 | 415 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2017 | 60 | 0.040 |
Why?
| | Patient Selection | 1 | 2000 | 687 | 0.040 |
Why?
| | Cost of Illness | 1 | 2019 | 282 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2017 | 212 | 0.040 |
Why?
| | Risk-Taking | 1 | 1999 | 353 | 0.040 |
Why?
| | Data Collection | 2 | 2014 | 658 | 0.040 |
Why?
| | Health Care Costs | 1 | 1999 | 384 | 0.040 |
Why?
| | Prejudice | 1 | 2015 | 55 | 0.040 |
Why?
| | Health Services Research | 1 | 2018 | 395 | 0.040 |
Why?
| | Cancer Care Facilities | 1 | 2015 | 36 | 0.040 |
Why?
| | Poverty Areas | 1 | 2014 | 37 | 0.040 |
Why?
| | Poverty | 1 | 2018 | 436 | 0.040 |
Why?
| | Organizational Innovation | 1 | 2015 | 140 | 0.040 |
Why?
| | Insurance Coverage | 1 | 2015 | 204 | 0.030 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 204 | 0.030 |
Why?
| | Insurance, Health | 1 | 2015 | 256 | 0.030 |
Why?
| | Program Development | 1 | 2015 | 380 | 0.030 |
Why?
| | Prevalence | 2 | 2010 | 2329 | 0.030 |
Why?
| | National Cancer Institute (U.S.) | 1 | 2011 | 29 | 0.030 |
Why?
| | Sickness Impact Profile | 1 | 2011 | 64 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2015 | 6709 | 0.030 |
Why?
| | Smoking | 1 | 1999 | 1620 | 0.030 |
Why?
| | Adolescent | 3 | 2019 | 18208 | 0.030 |
Why?
| | Haplotypes | 1 | 2012 | 544 | 0.030 |
Why?
| | Population Surveillance | 1 | 2013 | 427 | 0.020 |
Why?
| | Premenopause | 1 | 2009 | 115 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2013 | 1211 | 0.020 |
Why?
| | Receptors, Progesterone | 1 | 2011 | 335 | 0.020 |
Why?
| | Decision Making | 1 | 2015 | 748 | 0.020 |
Why?
| | Receptor, ErbB-2 | 1 | 2011 | 311 | 0.020 |
Why?
| | Body Size | 1 | 2009 | 96 | 0.020 |
Why?
| | Body Composition | 1 | 2013 | 737 | 0.020 |
Why?
| | Epidemiologic Methods | 1 | 2008 | 79 | 0.020 |
Why?
| | Parity | 1 | 2008 | 101 | 0.020 |
Why?
| | Women's Health | 1 | 2009 | 254 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 567 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2011 | 530 | 0.020 |
Why?
| | Societies, Medical | 1 | 2011 | 756 | 0.020 |
Why?
| | Pregnancy | 2 | 2008 | 5006 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3086 | 0.020 |
Why?
| | Attitude to Health | 1 | 2009 | 402 | 0.020 |
Why?
| | Motor Activity | 1 | 2011 | 782 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2021 | 10640 | 0.020 |
Why?
| | Diabetes, Gestational | 1 | 2007 | 254 | 0.020 |
Why?
| | Child | 2 | 2015 | 16586 | 0.010 |
Why?
| | Child, Preschool | 1 | 2015 | 9417 | 0.010 |
Why?
| | Cultural Characteristics | 1 | 2000 | 68 | 0.010 |
Why?
| | Language | 1 | 2000 | 230 | 0.010 |
Why?
|
|
Risendal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|